Paediatric Haematology and Oncology
Simon Bailey, Rod Skinner
Oxford University Press, 2010 - Medical - 598 pages
While survival rates for children with cancer have increased in recent times, the increased use of more aggressive therapies has brought with it significant adverse effects. Therefore, the aim of pediatric oncologists has become to achieve "cure at least cost" by the appropriate reduction of the intensity and/or duration of treatment in carefully identified good prognosis patients.
By comprehensively covering these issues, this handbook aims to provide residents in pediatric hematology and oncology, as well as staff in related medical or other healthcare disciplines, with an easily accessible source of information about the basic principles of childhood cancer and leukemia, as well as much of the more detailed specialist knowledge required to care for children with these conditions. Divided into sections to allow quick access to the necessary information, the handbook covers general principles of diagnosis and treatment, short and long term care, and oncological emergencies before moving on to chapters on specific disease. Normal values and useful websites are also included for reference.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Section 2 General approaches to suspected cancer
Section 3 Haematological and oncological emergencies
Section 4 General principles
Section 5 Supportive care
Section 6 Longterm followup
Section 7 Benign haematological diseases
Section 8 Malignant haematological diseases
Section 9 Solid tumours
Other editions - View all
abdominal abnormalities acute GvHD adult allogeneic and/or antibiotic antibody aplastic anaemia assessment associated biopsy bleeding blood bone marrow failure brain tumours cause chemotherapy childhood cancer chromosome chronic ciclosporin cisplatin Clinical features complications congenital CVAD cyclophosphamide cytogenetic deficiency diagnosis disease donor dose drugs effects especially etoposide factor VIII fungal G-CSF gene genetic germ cell tumours germinoma glioma GvHD haemophilia haemopoietic stem cell haemorrhage hepatic HSCT ifosfamide immunosuppressive infection inhibitors intentionally left blank lesions liver lymphoma malignancy medulloblastoma metastatic methotrexate mucosal mutation myeloid leukaemia neonatal neuroblastoma neutropenia normal occur ofthe oncology oral paediatric pain patients platelet post-HSCT potential present prognosis prophylaxis protein protocols radiotherapy rare red cell reduce relapse renal resection respiratory retinoblastoma Risk factors sarcoma scan serum severe spinal stem cell transplantation steroids surgery surgical survival symptoms syndrome therapy thrombocytopenia thrombosis tissue toxicity transfusion treatment usually venous vincristine viral Wilms